dc.contributor.author | Dag, Kenan | |
dc.contributor.author | Karabağ, Sevil | |
dc.date.accessioned | 2023-05-06T17:19:33Z | |
dc.date.available | 2023-05-06T17:19:33Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 2149-7893 | |
dc.identifier.issn | 2536-507X | |
dc.identifier.uri | https://doi.org/10.4274/cjms.2021.2021-117 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/11849 | |
dc.description.abstract | BACKGROUND/AIM: We aimed to determine erythroblast transformation-specific-related gene (ERG) and c-erbB2 expression in patients with adenocarcinoma of the prostate and to investigate the association of these proteins with tumor growth and/or Gleason score, which is the main prognostic marker in these patients. MATERIALS AND METHODS: Radical prostatectomy materials of 59 patients with acinar adenocarcinoma were included in this study. Immunohistochemical analysis for ERG and c-erbB2 was performed. The association of ERG and c-erbB2 expressions with International Society of Urologic Pathologists (ISUP) grade, tumor volume and patient age was investigated. RESULTS: ISUP grade was 1 (equivalent to a Gleason score of 6) in 23 tumors while the rest of the cases were Gleason score >6 tumors. ERG expression was detected in 37.5% of the cases. None of the cases had c-erbB2 expression. There was no significant difference in ERG staining between the low-risk (ISUP 1) and high-risk (ISUP >1) groups (p=0.602). Evaluation of all ISUP groups with the Kruskal-Wallis test showed no significant difference across the groups in terms of ERG expression (p=0.374). CONCLUSION: The present study reflects the ERG expression rate (37.5%) in patients with carcinoma of the prostate in Turkey. Our findings support that ERG overexpression is involved in the pathogenesis but has no association with histological grade in prostate carcinoma. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Galenos Publ House | en_US |
dc.identifier.doi | 10.4274/cjms.2021.2021-117 | |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Prostate carcinoma | en_US |
dc.subject | Gleason score | en_US |
dc.subject | ERG | en_US |
dc.subject | c-erbB2 | en_US |
dc.subject | Gene Amplification | en_US |
dc.subject | Transcription Factor | en_US |
dc.subject | Protein Expression | en_US |
dc.subject | Cancer | en_US |
dc.subject | Her-2/Neu | en_US |
dc.subject | Fusion | en_US |
dc.subject | Overexpression | en_US |
dc.subject | Oncoprotein | en_US |
dc.subject | Society | en_US |
dc.title | The Association of ERG and c-erbB2 Expressions With Gleason Scoring in Adenocarcinomas of the Prostate | en_US |
dc.type | article | en_US |
dc.relation.ispartof | Cyprus Journal Of Medical Sciences | en_US |
dc.department | Enstitüler, Sağlık Bilimleri Enstitüsü, Tümör Biyolojisi ve İmmünolojisi Ana Bilim Dalı | en_US |
dc.department | Fakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Tıbbi Patoloji Ana Bilim Dalı | en_US |
dc.authorid | karabag, sevil/0000-0002-8855-3798 | |
dc.identifier.volume | 7 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 196 | en_US |
dc.identifier.endpage | 200 | en_US |
dc.institutionauthor | Dag, Kenan | |
dc.institutionauthor | Karabağ, Sevil | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.wos | WOS:000886750700008 | en_US |